Sleep Disorder Drug Discovery Service
After decades of accumulation, Creative Biolabs has developed into a pioneer in the field of neuroscience. With a comprehensive platform and dedicated scientists, we are confident in providing standard and custom in vivo and in vitro assays to accelerate preclinical sleep disorders drug discovery.
Introduction to Sleep Disorder
Sleep has long been considered a sophisticated biological process. While sleeping, the body and brain are not at rest, they do a lot of pivotal work and help keep us healthy. Therefore, physical and mental health and daily activities can be severely impacted when sleep is problematic. Some of the hallmarks of sleep disorder include lethargy, irregular breathing, and increased movement during sleep. As we all know, narcolepsy and insomnia are typical sleep troubles in daily life. A variety of factors are closely related to sleep disorders. For instance, various diseases, such as lung disease, anxiety, and depression can adversely affect sleep. In addition to this, drugs and genetics are also closely related to sleep problems. Notably, caffeine and alcohol, irregular schedules, and aging also contribute to the disorder. Sleep disorders can usually be improved with regular sleep habits. Chronic insomnia is often treated with a combination of sleep medication and behavioral techniques, such as cognitive behavioral therapy. Also, some antidepressants are valid to treat insomnia.
Fig.1 Various neuropsychiatric disorders that may coexist with narcolepsy. (BaHammam, 2020)
Our Capabilities in Sleep Disorder Drug Discovery
As a leader in drug discovery for neurological diseases, Creative Biolabs is confident in accelerating drug discovery research by using our industry-leading portfolio of drug discovery solutions. Our integrated approach has been successful in delivering timely and cost-effective solutions and generating new intellectual property. A wide range of in vivo and in vitro models as well as characteristic assays are the foundation of our high-quality service.
Fig.2 Sleep disorder drug discovery service. (Creative Biolabs)
Various Animal Models
Despite many differences in sleep between animals and humans, there are many similarities between humans and rodents in sleep homeostasis regulation, sensitivity to endogenous and environmental factors, and responses to wake-promoting and hypnotic drugs. This is the premise of using animal models to study sleep disorders. In short, animal models are essential to screen potential target compounds. At Creative Biolabs, animal models for prevalent sleep disorders are available, such as animal models of insomnia, narcolepsy, restless legs syndrome, and sleep apnea.
Featured Cellular Models
- Primary Neuronal Cell Culture Models
- Human iPSC Derived Neuronal Cell Culture Models
- Organotypic Brain Slice Models
What Can We Do?
- Drug Combination Assay
- Functional Assays
- Toxicity Assays
- Neuronal Plasticity Assay
- Behavioral Testing Services
Our experienced scientists with strong expertise in sleep disorders drug discovery are committed to advancing your most promising preclinical drug screens. Specializing in standard and custom in vivo and in vitro assays, we focus on providing our clients with flexible and cost-effective solutions. If you have any difficulties with your drug development project, please feel free to contact us to discuss your project.
Reference
- BaHammam, A. S.; et al. Neuropsychiatric correlates of narcolepsy. Current Psychiatry Reports. 2020, 22(8): 1-11.
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Anti-TREM2 Antibody (NRP-0422-P792) (Cat#: NRP-0422-P792)
- iNeuMab™ Anti-GD2 Antibody (NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3503) (Cat#: NRZP-1022-ZP3503)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- iNeuMab™ Anti-Amyloid Beta 1-15 Antibody (NRP-0422-P867) (Cat#: NRP-0422-P867)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- Rat Muller Cell (Cat#: NCL2110P040)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Rat Microglia Cell Line HAPI, Immortalized (Cat#: NCL2110P015)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)